AIS
BLFS icon

Advocate Investing Services’s BioLife Solutions BLFS Stock Holding History

Advocate Investing Services’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$621 Hold
22
– – ﹤0.01% 439
2026
Q1 		$420 Hold
22
– – ﹤0.01% 429
2025
Q4 		$532 Buy
+22
New +$576 ﹤0.01% 417

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Advocate Investing Services's BLFS Position: Q2 2026 in Review

Advocate Investing Services held its BioLife Solutions (BLFS) position steady in Q2 2026 at 22 shares worth $621. The position accounts for ﹤0.01% of the portfolio, ranked #439.

Advocate Investing Services first reported a position in BLFS in Q4 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Advocate Investing Services held 22 shares of BioLife Solutions worth $621 as of Q2 2026.
  • Advocate Investing Services left its BioLife Solutions share count unchanged in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Advocate Investing Services's portfolio in Q2 2026, its #439 holding.
  • Advocate Investing Services first reported a position in BioLife Solutions in Q4 2025 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Advocate Investing Services's 13F filing for Q2 2026, filed 29 Jul 2026.